• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯基噻唑基脲和氨基甲酸酯衍生物作为细菌细胞壁生物合成的新型抑制剂

Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis.

作者信息

Francisco Gerardo D, Li Zhong, Albright J Donald, Eudy Nancy H, Katz Alan H, Petersen Peter J, Labthavikul Pornpen, Singh Guy, Yang Youjun, Rasmussen Beth A, Lin Yang-I, Mansour Tarek S

机构信息

Chemical Sciences and Infectious Diseases, Wyeth Research, Pearl River, NY 10965, USA.

出版信息

Bioorg Med Chem Lett. 2004 Jan 5;14(1):235-8. doi: 10.1016/j.bmcl.2003.09.082.

DOI:10.1016/j.bmcl.2003.09.082
PMID:14684334
Abstract

Over 50 phenyl thiazolyl urea and carbamate derivatives were synthesized for evaluation as new inhibitors of bacterial cell-wall biosynthesis. Many of them demonstrated good activity against MurA and MurB and gram-positive bacteria including MRSA, VRE and PRSP. 3,4-Difluorophenyl 5-cyanothiazolylurea (3p) with clog P of 2.64 demonstrated antibacterial activity against both gram-positive and gram-negative bacteria.

摘要

合成了50多种苯基噻唑基脲和氨基甲酸酯衍生物,以评估其作为细菌细胞壁生物合成新抑制剂的性能。其中许多化合物对MurA和MurB以及包括耐甲氧西林金黄色葡萄球菌(MRSA)、耐万古霉素肠球菌(VRE)和耐青霉素肺炎链球菌(PRSP)在内的革兰氏阳性菌表现出良好的活性。脂水分配系数(clog P)为2.64的3,4-二氟苯基5-氰基噻唑基脲(3p)对革兰氏阳性菌和革兰氏阴性菌均表现出抗菌活性。

相似文献

1
Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis.苯基噻唑基脲和氨基甲酸酯衍生物作为细菌细胞壁生物合成的新型抑制剂
Bioorg Med Chem Lett. 2004 Jan 5;14(1):235-8. doi: 10.1016/j.bmcl.2003.09.082.
2
Exploration of (3-benzyl-5-hydroxyphenyl)carbamates as new antibacterial agents against Gram-positive bacteria.探索(3-苄基-5-羟基苯基)氨基甲酸酯类化合物作为新型抗革兰氏阳性菌的抗菌药物。
Arch Pharm (Weinheim). 2020 Mar;353(3):e1900294. doi: 10.1002/ardp.201900294. Epub 2020 Jan 2.
3
2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis.2-苯基-5,6-二氢-2H-噻吩并[3,2-c]吡唑-3-醇衍生物作为细菌细胞壁生物合成的新型抑制剂
Bioorg Med Chem Lett. 2003 Aug 4;13(15):2591-4. doi: 10.1016/s0960-894x(03)00471-2.
4
Synthesis and antibacterial activity of 11,12-carbamate-3-O-acyl erythromycin derivatives.11,12-氨基甲酸酯-3-O-酰基红霉素衍生物的合成及其抗菌活性
J Asian Nat Prod Res. 2009 Oct;11(10):880-97. doi: 10.1080/10286020903176461.
5
Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase.基于莫能菌素(一种细菌转糖基酶抑制剂)二糖结构的合成类似物的抗菌活性。
Microbiology (Reading). 2000 Dec;146 Pt 12:3129-3140. doi: 10.1099/00221287-146-12-3129.
6
Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.不结合D-丙氨酰-D-丙氨酸而抑制肽聚糖生物合成的万古霉素衍生物。
Science. 1999 Apr 16;284(5413):507-11. doi: 10.1126/science.284.5413.507.
7
Pulvinones as bacterial cell wall biosynthesis inhibitors.双氢黄酮醇作为细菌细胞壁生物合成抑制剂。
Bioorg Med Chem Lett. 2006 Jan 1;16(1):176-80. doi: 10.1016/j.bmcl.2005.09.021. Epub 2005 Oct 10.
8
Synthesis and antibacterial activity of tert-butyl [1-benzyl-2[(4-aryl-2-thiazolyl)hydrazono]ethyl]carbamate derivatives.叔丁基[1-苄基-2-[(4-芳基-2-噻唑基)腙基]乙基]氨基甲酸酯衍生物的合成及抗菌活性
Arch Pharm (Weinheim). 2007 Jun;340(6):310-4. doi: 10.1002/ardp.200600200.
9
Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.新型具有广谱抗菌活性的阳离子查尔酮衍生物的合成与抗菌评价。
Eur J Med Chem. 2018 Jan 1;143:905-921. doi: 10.1016/j.ejmech.2017.12.009. Epub 2017 Dec 5.
10
3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria.3,5-二氧代吡唑烷,UDP-N-乙酰烯醇丙酮酸葡糖胺还原酶(MurB)的新型抑制剂,对革兰氏阳性菌具有活性。
Antimicrob Agents Chemother. 2006 Feb;50(2):556-64. doi: 10.1128/AAC.50.2.556-564.2006.

引用本文的文献

1
Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug resistant bacteria in respiratory tract infections.脂质体中的纳米颗粒:一种提高呼吸道感染多重耐药菌抗生素选择性的平台。
Drug Deliv Transl Res. 2025 Apr;15(4):1193-1209. doi: 10.1007/s13346-024-01662-2. Epub 2024 Jul 24.
2
Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target.抗生素和抗生素耐药性——作为抗菌靶点的 Mur 连接酶。
Molecules. 2023 Dec 13;28(24):8076. doi: 10.3390/molecules28248076.
3
Novel tetrahydronaphthalen-1-yl-phenethyl ureas: synthesis and dual antibacterial-anticancer activities.
新型四氢萘-1-基-苯乙脲:合成及其抗菌-抗癌双重活性
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2286925. doi: 10.1080/14756366.2023.2286925. Epub 2023 Dec 7.
4
Screening and molecular dynamics simulation of compounds inhibiting MurB enzyme of drug-resistant : An approach.耐药性MurB酶抑制剂化合物的筛选及分子动力学模拟:一种方法
Saudi J Biol Sci. 2023 Aug;30(8):103730. doi: 10.1016/j.sjbs.2023.103730. Epub 2023 Jul 4.
5
Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents.抗结核分枝杆菌抑制剂:结构见解与新型药物开发的未来方向
Pharmaceuticals (Basel). 2023 Mar 1;16(3):377. doi: 10.3390/ph16030377.
6
Breaking down the cell wall: Still an attractive antibacterial strategy.破坏细胞壁:仍然是一种有吸引力的抗菌策略。
Front Microbiol. 2022 Sep 23;13:952633. doi: 10.3389/fmicb.2022.952633. eCollection 2022.
7
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics.二芳基脲类化合物:从抗肿瘤药物重新定位为抗微生物药物或针对新型大流行疾病的多靶点药物。
Antibiotics (Basel). 2021 Jan 19;10(1):92. doi: 10.3390/antibiotics10010092.
8
The MurG glycosyltransferase provides an oligomeric scaffold for the cytoplasmic steps of peptidoglycan biosynthesis in the human pathogen Bordetella pertussis.人病原体百日咳博德特氏菌的 MurG 糖基转移酶为肽聚糖生物合成的细胞质步骤提供了一个寡聚支架。
Sci Rep. 2019 Mar 15;9(1):4656. doi: 10.1038/s41598-019-40966-z.
9
Small molecule fluoride toxicity agonists.小分子氟化物毒性激动剂。
Chem Biol. 2015 Apr 23;22(4):527-534. doi: 10.1016/j.chembiol.2015.03.016.
10
Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.结核分枝杆菌肽聚糖生物合成酶的结构和功能特征作为药物开发靶点
Tuberculosis (Edinb). 2015 Mar;95(2):95-111. doi: 10.1016/j.tube.2015.01.006. Epub 2015 Jan 29.